XBIO - Xenetic Biosciences, Inc. Market Capitalization

Graphic logo of Xenetic Biosciences (XBIO)

Xenetic Biosciences (XBIO) operations are shielded from trade conflicts and sanctions due to the humanitarian status of the oncobiotech firm. The company relies on the XCART system for cellular pathway modulation, establishing unique patent barriers through personalized molecules. The market trend for the asset shown on this price chart, where capitalization stands at 0.00, is further bolstered by the development of the DNase platform, which targets the degradation of neutrophil extracellular traps in neoplasms and future licensing opportunities.

XBIO Xenetic Biosciences, Inc.: Market Value in the range 07/04/2022 - 11/17/2026

Metric breakdowns and analytics for Xenetic Biosciences Inc. (XBIO)

- current price and projected stock value:
Fundamental company valuation:Xenetic Biosciences, Inc. XBIO
Product sample of Xenetic Biosciences, Inc.

An investment audit of the issuer requires a thorough analysis of asset liquidity before entering a position. This metric is calculated as the product of the current share price and the total number of issued securities. For Xenetic Biosciences (XBIO), the valuation is based on expectations for CAR-T platforms and the partnership with Takeda, rather than current earnings. FDA regulatory barriers create high volatility in the market value of all the company's issued shares. This chart reflects speculative demand for biotechnological potential.

Competitors of Xenetic Biosciences (XBIO)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|CG Oncology Corp (CGON) - Market Value|Market Capitalization URGN|BCAX (Bicara Corp) - Market Capitalization|Market Valuation Personalis Corp (PSNL)|Market Capitalization ERAS|Market Capitalization delcath.com (DCTH)|Market Value YmAbs YMAB|AURA: Market Capitalization|Candel Therapeutics, Inc. - Market Capitalization|Accuray Inc. (ARAY) - Market Valuation|SELLAS Life Sciences Group Inc. (SLS) - Market Value|Market Value actuatetherapeutics.com (ACTU)|Market Value Citius Oncology|HURA: Market Value|Market Valuation TARA (Protara)|FATE (Fate Therapeutics Corp) - Market Value|Market Capitalization WHWK (Aadi Bioscience Inc)|TCRX - Market Valuation|CSBR: Market Valuation|XBIT - Market Capitalization|CVM: Market Capitalization|OS Therapies Inc - Market Value|RADX (radiopharmtheranostics.com) - Market Capitalization|Market Value Artiva Biotherapeutics, Inc. ARTV|Market Capitalization ANL|Market Value VERU (Veru)|Market Capitalization TPST (tempesttx.com)|Xilio - Market Value|RENB - Market Value|Market Value MURA (muraloncology.com)|Kairos Pharma Inc (KAPA) - Market Value|OnKure (OKUR) - Market Capitalization|Market Value w2.cytomed.sg|Curis (CRIS) - Market Capitalization|Market Value Apollomics, Inc. (APLM)|Market Valuation tharimmune.com THAR|Market Capitalization ADVB (Advanced Biomed)|GNPX: Market Capitalization|calidibio.com - Market Capitalization|Market Value Sunshine Biopharma|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group